Publicacións (12) Publicacións de Carla Eugenia Cacho Antonio

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  3. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

    Acta Diabetologica, Vol. 59, Núm. 2, pp. 163-170

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

  2. Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 105-108

  3. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  4. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  5. Pericarditis constrictiva

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 43, pp. 2517-2531

  6. Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement

    Circulation. Cardiovascular interventions, Vol. 14, Núm. 2, pp. e009342

  7. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

    Clinical Research in Cardiology, Vol. 110, Núm. 9, pp. 1464-1472

  8. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11